कोशिश गोल्ड - मुक्त
Procter & Gamble to cut 7,000 jobs
Mint Mumbai
|June 06, 2025
Procter & Gamble (P&G) said on Thursday it would cut 7,000 jobs, or about 6%, of its total workforce over the next two years, as part of a new restructuring plan to counter uneven consumer demand and higher costs due to tariff uncertainty.
-
The world's largest consumer goods company also plans to exit some product categories and brands in certain markets, executives said at a Deutsche Bank Consumer Conference in Paris, adding the program could likely include some divestitures without giving d
यह कहानी Mint Mumbai के June 06, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
BUDGET TO KEEP FISC STEADY AMID GLOBAL STORM
The Union Budget for FY27 is being formulated against the backdrop of some positive surprises, despite a highly volatile and uncertain global environment.
3 mins
January 23, 2026
Mint Mumbai
Govt may raise allocation for power distribution reforms
Revamped Distribution Sector Scheme is likely to get ₹18,000 crore in the FY27 budget
2 mins
January 23, 2026
Mint Mumbai
Pet care startups eye users to compete with FMCG giants
Direct-to-consumer (D2C) pet care brands are leaning on subscription models to lock in customers, betting that repeat purchases can help them counter the scale and distribution advantage of India's largest packaged consumer goods players as the niche segment heats up.
2 mins
January 23, 2026
Mint Mumbai
IT majors face weak FY26 despite Q3 earnings beats
Four top IT services firms are heading into Q4 with weaker full-year trajectories than last year
3 mins
January 23, 2026
Mint Mumbai
Here's how to build an education fund in a high-inflation economy
With education inflation running at 10-12% annually, far outpacing CPI, parents must rethink savings strategies
4 mins
January 23, 2026
Mint Mumbai
Zydus launches cancer biosimilar
Zydus Lifesciences has launched its biosimilar of anticancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the patented version.
1 min
January 23, 2026
Mint Mumbai
AI accessibility: We need to clearly define what it means
As the world approaches the India AI Summit 2026 , the conversation on AI has evolved beyond algorithmic efficiency to encompass the more significant issues of digital sovereignty and ethics.
3 mins
January 23, 2026
Mint Mumbai
Retail boosts IPO odds via parent shares
A smart move? Investors are reviving an old strategy by buying parent shares ahead of subsidiary IPOs.
3 mins
January 23, 2026
Mint Mumbai
Behind Kalyan Jewellers’ stock slump
Kalyan Jewellers has had a rough start to 2026, with the stock sliding around 22% this calendar year, lagging peers.
3 mins
January 23, 2026
Mint Mumbai
Family-run Duroflex gears up for IPO
After more than six decades as a privately held, family-run business, mattress maker Duroflex believes it is ready for the public markets, top executives of the company told Mint.
2 mins
January 23, 2026
Listen
Translate
Change font size

